Biohaven Ltd. (BHVN)
NYSE·Healthcare·Biotechnology
$12.62
-1.21%
Mkt Cap $2.36B
Analyst Ratings
Buy
5
Hold
2
Sell
1
Price Target (27 analysts)
$15.40
Range $10.00 – $23.00
Implied Upside
+22.0%
Consensus $15.40 vs current $12.62
NYSE·Healthcare·Biotechnology
$12.62
-1.21%
Mkt Cap $2.36B
Buy
5
Hold
2
Sell
1
Price Target (27 analysts)
$15.40
Range $10.00 – $23.00
+22.0%
Consensus $15.40 vs current $12.62